Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Duobrii in the Management of Acne Keloidalis Nuchae (AKN)

NCT05608499 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT05608499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05608499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Duobrii in the Management of Acne Keloidalis Nuchae (AKN)
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Phase 3
Overall status
Terminated
Start date
October 26, 2022
Completion date
April 15, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne keloidalis nuchae, akn